ÖZET
Congenital pleural effusion is a rare clinical entity with an estimated incidence of 1/10.000-15.000 pregnancies (1) . It has a wide spectrum of etiology from unknown etiology (idiopathic) to inflammatory association, chromosomal anomalies or structural malformations. The incidence of isolated pleural effusion in neonate and its association with inflammation or genetic syndromes have not been exactly known. Here, we report 2 neonates with isolated congenital pleural effusion, one of which was associated with down syndrome and the other with empyema and bloodstream infection caused by Burkholderia gladioli septicemia.
CASE REPORT Case 1
A newborn, from 43-year-old gravida 4 para 3 woman, at 31 weeks gestational age was delivered by cesarean section without respiratory distress. He had been diagnosed as polyhydroamnios and unilateral fetal pleural effusion on the right side by fetal ultrasonogram at 30 weeks of gestational age. The initial Apgar scores were 7 at 1 min and 8 at 5 min. After admission to neonatal intensive care unit (NICU), he had minimal tacypne (66/min) and retractions without obvious respiratory insufficiency. Chest radiograph initially showed increased opacity of the right hemithorax with pleural effusion ( Figure 1A ). The baby had epicanthal folds, lowset ears, bilateral simian line and fifth-finger clinodactyly. There was no evidence of ascites, subcutaneous edema or pericardial effusion. Ultrasonogram confirmed anechoic fluid collection with 2 cm width in the right hemithorax. As there was no respiratory insufficiency, the infant was begun to follow up with conservative management. Repeated chest radiographs and weekly ultrasonogram were performed in order to detect the clinical course of the effusion. There was no rapid enlargement of the effusion on serial ultrasound and the pleural fluid resolved spontaneously over a period of three weeks. The karyotype was 47, XY, +21, so he was diagnosed as down syndrome. Follow-up chest radiograph showed no recurred pleural effusion over the next 6 months ( Figure 1B) .
Case 2
A 33-year-old multipar woman, gravida 4 para 2, was referred to obstetrics and gynecology department of our hospital at third-trimester for evaluation of a unilateral pleural effusion in her fetus. Follow-up prenatal ultrasounds demonstrated persistence of the pleural effusion and premature prelabor rupture of the membranes (PPROM) occurred. A 3900 g infant girl was born at 38 weeks of gestation by emergency cesarean delivery for fetal distress. On admission to NICU, respiratory insuffciency required intubation and positive pressure ventilation. The initial chest radiograph showed unilateral pleural effusion on the right hemithorax with the collapsed right lung ( 
DISCUSSION
Pleural effusion in the fetus may cause pulmonary hypoplasia and is a risk factor for severe respiratory insufficiency after birth. It may also lead to the development of generalized hydrops and polyhydroamnios, which are associated with preterm delivery, neonatal asphyxia and perinatal death (2) . The natural history of fetal pleural effusion is not well understood and it can regress, remain stable or worsen in prognosis. Auberd et al. reported spontaneous regression in 22% of 204 cases of primary fetal pleural effusion (3). Spontaneous regression can even occur with large effusions and, very rarely, in the presence of hydrops (1,4,5); however, it is more likely when the diagnosis is made early in the second trimester, if the effusion is unilateral and in the absence of hydrops or hydraminios (3). Premature delivery and the presence of hydrops have been reported as poor indicators while gestation at diagnosis and hydramnios had no impact on outcome. When effusions were bilateral, outcome has been worse in some studies but not in others (1, 3, 6, 7) .
The content of the isolated pleural effusion is mostly chylous, resulting from a malformation or leakage in the fetal thoracic duct. However, in a minority of the cases, the content of the effusion is serous. Some authors reported that serous congenital pleural effusion may be associated with underlying thoracic cause such as primary lymphangiectasia, congenital cystic adenomatoid malformation, bronchopulmonary dysplasia, diaphragmatic hernia, chest wall hamartoma and pulmonary vein atresia (8-10). Several cases have been reported about congenital or fetal pleural effusion with chromosomal anomaly such as down syndrome and turner syndrome (11) (12) (13) . Most of these pleural effusion were chylothorax or associated with hydrops (14, 15) . However, like one of our case, isolated non-chylous pleural effusion has been rarely reported (16, 17) . Hence, karyotyping is indicated in a fetus or newborn with isolated pleural effusion for the evaluation of associated chromosomal anomaly (11) .
Pleural fluid analysis is helpful in determining the etiology of effusion, either infectious or non-infectious. Pleural pH is a useful marker of differentiation between transudative and exudative effusions. Pleural fluid with a pH less than 7.3 is classified as exudative and is most likely infectious, where as a pH greater than 7.45 categorizes the fluid as transudative. Additionally, high white blood cell counts with neutrophil predomination and fluid culture are other supportive findings for infectious pleural fluid. Although B. gladioli is mainly known as a plant pathogen, the spectrum of infections caused by B. gladioli includes respiratory tract infections and septicemia (18) . The origin of this microorganism in our second case is not clear. Congenital infectious pleural effusion with PPROM history and identification of the microorganism from both thoracentesis and blood culture yielded us that this gram-negative microorganism was responsible from all profile.
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Tuberk Toraks 2012; 60(1): 52-55 For a long time, the rarity of this condition and its unpredictable clinical course prevented a uniform approach to management, and indeed, gave rise to a great deal if uncertanity about the usefullness of any prenatal intervention for fetal pleural effusion. The metaanalysis by Weber and Philipson was the first to lend support to the idea of prenatal intervention for fetuses with pleural effusion (6) . The prenatal treatment to the fetus include thoracentesis, pleuro-amniotic shunting and pleurodesis (1, 19, 20) . Despite these in utero interventions in selected cases, management of pleural effusions in neonates should be also conservative depending on the clinical course of the baby, if possible.
In conclusion, variable etiologic factors should be investigated in cases with fetal pleural effusions and necassary interventions should be performed in selected cases both in utero and ex utero.
